Axonics (NASDAQ:AXNX) quickly rose 1% after Boston Scientific (BSX) said it will no longer offer Coaptite as of Nov. 1. Investors believe the announcement may mean that Boston Scientific (BSX) agreed ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2024-10-09 11:24:00